Basic principles in preclinical cancer chemotherapy.
Brock
N
N
Pohl
J
J
Schneider
B
B
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical / Q000379:methods; D007069:Ifosfamide / Q000493:pharmacokinetics / Q000627:therapeutic use; D008466:Mechlorethamine / Q000493:pharmacokinetics / Q000627:therapeutic use; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000493:pharmacokinetics / Q000627:therapeutic use; D051381:Rats
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D008466:Mechlorethamine; D003520:Cyclophosphamide; C003726:trofosfamide; C004933:nornitrogen mustard; D007069:Ifosfamide